Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial.
Najmolsadat AtefiAzadeh GoodarziTaghi RiahiNiloofar KhodabandehlooMahshid T TaherNiloufar Najar NobariFarnoosh SeirafianpourZeinab MahdiAmir BaghestaniRohollah ValizadehPublished in: Immunity, inflammation and disease (2023)
saturation and faster reduction of the CRP level and inflammation or could be effective for better controlling of COVID-19 or its therapy-related side effects.